RSVPreF and Beyond: The Next Generation of Respiratory Syncytial Virus Treatment
Respiratory Syncytial Virus (RSV) is a common viral infection that affects the respiratory tract, particularly in young children and older adults. The burden of Respiratory Syncytial Virus-related illnesses is significant, leading to millions of hospitalizations worldwide each year. As a result, the respiratory syncytial virus treatment market has emerged as a complex and lucrative space, with billions of dollars at stake. In this blog post, we will explore the current therapies available for RSV, the challenges they face, and the promising upcoming therapies. Current Respiratory Syncytial Virus Therapies, their Challenges, and Upcoming Therapies RSV treatment is currently mostly initiated with supportive care, which includes appropriate hydration, oxygen supplementation, and antipyretics to lower fever. These methods, however, do not specifically target the virus, creating a huge therapy gap. The complexity of the virus, the dearth of useful animal models, and the difficulty in eli...